Adimmune Corp
TWSE:4142

Watchlist Manager
Adimmune Corp Logo
Adimmune Corp
TWSE:4142
Watchlist
Price: 19.25 TWD -0.26%
Market Cap: 8.3B TWD

Wall Street
Price Targets

Price Targets Summary
Adimmune Corp

There are no price targets for Adimmune Corp.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Adimmune Corp Competitors:
Price Targets
ZYME
Zymeworks Inc
36% Upside
HPHA
Heidelberg Pharma AG
132% Upside
CNTB
Connect Biopharma Holdings Ltd
201% Upside
ALCLS
Cellectis SA
58% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
29% Upside
ALEC
Alector Inc
38% Upside
MSB
Mesoblast Ltd
22% Upside
6855
Ascentage Pharma Group International
97% Upside

Revenue
Forecast

Revenue Estimate
Adimmune Corp

For the last 13 years the compound annual growth rate for Adimmune Corp's revenue is 14%. The projected CAGR for the next 2 years is 8%.

14%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Adimmune Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat

Net Income
Forecast

Net Income Estimate
Adimmune Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Adimmune Corp's stock price target?
Not Available

Adimmune Corp doesn't have any price targets made by Wall Street professionals.

What is Adimmune Corp's Revenue forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for Adimmune Corp's revenue is 14%. The projected CAGR for the next 2 years is 8%.

Back to Top